VITEK¿ 2 Compact 30, REF numbers: 27530 and 27530R (clinical), and 27630 and 17630R (industry) s...

FDA Device Recall #Z-3076-2017 — Class II — July 12, 2017

Recall Summary

Recall Number Z-3076-2017
Classification Class II — Moderate risk
Date Initiated July 12, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Biomerieux Inc
Location Hazelwood, MO
Product Type Devices
Quantity 9234 units

Product Description

VITEK¿ 2 Compact 30, REF numbers: 27530 and 27530R (clinical), and 27630 and 17630R (industry) software and reagent cards designed for the identification (ID) and antimicrobial susceptibility testing (AST) of bacteria and yeast.

Reason for Recall

Customers have reported that some VITEK¿ 2 cards are staying in preliminary status, not finalizing after ejection from the instrument, and not allowing cards in subsequent carousel slots to be processed. The issue was reported to occur on VITEK¿ 2 Compact 15 and Compact 30 systems following a system software update to version 8.01.

Distribution Pattern

Worldwide

Lot / Code Information

VITEK¿ 2 Compact 15 and Compact 30 instruments previously manufactured/installed with VITEK¿ 2 System software versions prior to 5.01, and currently being upgraded to version 8.01.

Other Recalls from Biomerieux Inc

Recall # Classification Product Date
Z-1236-2026 Class II VITEK 2 Gram-negative Susceptibility Cards Cont... Jan 5, 2026
Z-1464-2024 Class I VITEK 2 - AST Test kits (in vitro diagnostic te... Mar 14, 2024
Z-1201-2023 Class II MYLA comprises AST Filters in conjunction with ... Feb 6, 2023
Z-0798-2023 Class II VIDAS CLINICAL VIDAS LISTERIA 60T, CATALOG 30700 Nov 9, 2022
Z-0786-2023 Class II API STAPH 25 STRIPS+25 MEDIA, CATALOG 20500 Nov 9, 2022

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.